Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by C. Lezcano
Bevacizumab Plus Ipilimumab in Patients With Metastatic Melanoma
Cancer immunology research
Cancer Research
Immunology
Related publications
Panhypopituitarism in Metastatic Melanoma Patient Treated With Ipilimumab and Pembrolizumab
Journal of Cutaneous Immunology and Allergy
Response Assessment in Metastatic Melanoma Treated With Ipilimumab and Bevacizumab: CT Tumor Size and Density as Markers for Response and Outcome
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Serum Immunoregulatory Proteins as Predictors of Overall Survival of Metastatic Melanoma Patients Treated With Ipilimumab
Journal for ImmunoTherapy of Cancer
Oncology
Molecular Medicine
Pharmacology
Cancer Research
Allergy
Immunology
Pcn184 - Cost-Effectiveness of Nivolumab Plus Ipilimumab in Advanced Melanoma
Value in Health
Medicine
Health Policy
Public Health
Occupational Health
Environmental
Ipilimumab: An Anti-Ctla-4 Antibody for Metastatic Melanoma
Clinical Cancer Research
Cancer Research
Oncology
A Phase 2 Randomised Study of Veliparib Plus FOLFIRI±bevacizumab Versus Placebo Plus FOLFIRI±bevacizumab in Metastatic Colorectal Cancer
British Journal of Cancer
Cancer Research
Oncology
Hospitalization and Emergency Department Utilization in Patients With Advanced Melanoma Receiving Pembrolizumab vs. Ipilimumab Plus Nivolumab in US Academic Centers
Journal of Medical Economics
Health Policy
Clinical Efficacy and Safety of Bevacizumab Monotherapy in Patients With Metastatic Melanoma: Predictive Importance of Induced Early Hypertension
PLoS ONE
Multidisciplinary
Corrigendum: Association of CTLA-4 Gene Variants With Response to Therapy and Long-Term Survival in Metastatic Melanoma Patients Treated With Ipilimumab: An Italian Melanoma Intergroup Study
Frontiers in Immunology
Allergy
Immunology
